Cite
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America
MLA
Lalezari, Jacob P., et al. “Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America.” The New England Journal of Medicine, vol. 348, no. 22, May 2003, p. 2175. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.126537289&authtype=sso&custid=ns315887.
APA
Lalezari, J. P., Trottier, B., Jain Chung, Salgo, M., Henry, K., Walmsley, S., DeMasi, R., O’Hearn, M., Cohen, C., Donatacci, L., Montaner, J. S. G., Kuritzkes, D. R., Drobnes, C., Piliero, P. J., Eron, J. J., Jr., & Delehanty, J. (2003). Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. The New England Journal of Medicine, 348(22), 2175.
Chicago
Lalezari, Jacob P., Benoit Trottier, Jain Chung, Miklos Salgo, Keith Henry, Sharon Walmsley, Ralph DeMasi, et al. 2003. “Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America.” The New England Journal of Medicine 348 (22): 2175. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.126537289&authtype=sso&custid=ns315887.